Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Universal Ibogaine's share price for the quarter that ended in Apr. 2025 was $0.0218. Universal Ibogaine's Shares Outstanding (EOP) for the quarter that ended in Apr. 2025 was 308.61 Mil. Therefore, Universal Ibogaine's market cap for the quarter that ended in Apr. 2025 was $6.73 Mil.
Universal Ibogaine's quarterly market cap
increased
from Oct. 2024 ($2.35 Mil) to Jan. 2025 ($6.17 Mil) and
increased
from Jan. 2025 ($6.17 Mil) to Apr. 2025 ($6.73 Mil).
Universal Ibogaine's annual market cap
declined
from Jul. 2022 ($5.87 Mil) to Jul. 2023 ($1.92 Mil) but then
increased
from Jul. 2023 ($1.92 Mil) to Jul. 2024 ($2.31 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Universal Ibogaine's Enterprise Value for Today is $10.39 Mil.
Universal Ibogaine (OTCPK:IBOGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Universal Ibogaine Market Cap Related Terms
Universal Ibogaine Market Cap Historical Data
* Premium members only.
The historical data trend for Universal Ibogaine's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Universal Ibogaine's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Ibogaine Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Market Cap distribution charts can be found below:
* The bar in red indicates where Universal Ibogaine's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Universal Ibogaine's Market Cap for the fiscal year that ended in Jul. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Ibogaine (IBOGF) has a Market Cap of $8.67 Mil as of Jul. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Universal Ibogaine and its competitors.
Is Universal Ibogaine's Market Cap too high?
Universal Ibogaine's current Market Cap is $8.67 Mil. The Biotechnology industry median Market Cap is 120.54. Universal Ibogaine's value of $8.67 Mil is 92.8% below this industry median.
How does Universal Ibogaine's Market Cap compare to LABT and CALC?
Universal Ibogaine's Market Cap of $8.67 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 120.54. Universal Ibogaine's value of $8.67 Mil is 92.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 120.54, based on 1,422 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universal Ibogaine's current Market Cap of $8.67 Mil is 92.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Universal Ibogaine and its competitors. For the Biotechnology industry, the median Market Cap is 120.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universal Ibogaine's current Market Cap is $8.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Ibogaine stock overvalued right now?
Universal Ibogaine (IBOGF) has a current Market Cap of $8.67 Mil. The current Market Cap is $8.67 Mil and 92.8% below the Biotechnology industry median of 120.54. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Universal Ibogaine (IBOGF), the current Market Cap is $8.67 Mil as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IBOGF has been successfully added to your 